Cover Image
市場調查報告書

泛自閉症障礙 (ASD) 的預測:主要12大市場 (2015年∼2025年)

Autism Spectrum Disorders Forecast in 12 Major Markets 2015-2025

出版商 Black Swan Analysis 商品編碼 339837
出版日期 內容資訊 英文 56 Pages
訂單完成後即時交付
價格
Back to Top
泛自閉症障礙 (ASD) 的預測:主要12大市場 (2015年∼2025年) Autism Spectrum Disorders Forecast in 12 Major Markets 2015-2025
出版日期: 2015年09月01日 內容資訊: 英文 56 Pages
簡介

泛自閉症障礙 (ASD) 是發育障礙之一,包含了自閉症,廣泛性發育障礙 (PDD) 、非定型廣泛性發育障礙 (PDD-NOS) 、亞斯伯格症候群等。

本報告提供主要12大市場 (美國,法國,德國,義大利,西班牙,英國,巴西,日本,印度,丹麥,瑞典,中國) 的泛自閉症障礙 (ASD) 之目前患者數 (性別,年齡世代別) 調查分析,提供您目前得病率,加上ASD概要,危險因素,疾病診斷與預後,主要的症狀和併發症等系統性資訊。

圖表

簡介

病因

危險因素和預防

疾病診斷

變異:地區/各民族

疾病預後與臨床經過

疾病相關的主要併發症/特徵

患者數定量化手法

泛自閉症障礙 (ASD) 的得病率top line

ASD的主要併發症與特徵

  • ASD的種類
  • ASD的嚴重度
  • ASD患者的認識功能級
  • ASD患者的癲癇發作型
  • ASD患者的行動功能障礙
  • ASD患者的運動·肌肉疾病

簡稱

相關出版

患者基群線上資料庫

患者基群產品

價格的線上資料·平台

參考文獻

附錄

目錄
Product Code: AUTS0010915

Autism Spectrum Disorders (ASD) or Pervasive Developmental Disorder (PDD) defines a group of developmental disability disorders. In this report, disorders include: Autism, Pervasive Developmental Disorder not otherwise specified (PDD-NOS) and Asperger Syndrome. Attributes of these disorders can be grouped into three areas: communication difficulties, repetitive and stereotyped behaviour and social impairment, with a wide variation of symptoms which can occur for any given patient.

This report provides the current prevalent population for ASD across 12 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil, Japan, India, Denmark, Sweden and China) split by gender and 5-year age cohort. Along with the current prevalence, the report provides an overview of the type and severity of ASD, level of cognitive function and behavioural and motor dysfunction. The report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity. Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of ASD have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for ASD include:

  • ADHD
  • Epilepsy
  • Gastrointestinal problems
  • Motor function/ co-ordination problems
  • Anxiety
  • Depression
  • Hypotonia
  • Restless Sleep

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy

  • Able to quantify patient populations in global ASD's market to target the development of future products, pricing strategies and launch plans.
  • Gain further insight into the prevalence of the subdivided types of ASD and identify patient segments with high potential.
  • Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
  • Provide a level of understanding on the impact from specific co-morbid conditions on ASD's prevalent population.
  • Identify sub-populations within ASD which require treatment.
  • Gain an understanding of the specific markets that have the largest number of ASD patients.

Coverage

US, UK, FR, DE, IT, ES, JP, BR, CN, IN

Table of Contents

List of Tables and Figures

Introduction

Cause of the Disease

Risk Factors & Prevention

Diagnosis of the Disease

Variation by Geography/Ethnicity

Disease Prognosis &Clinical Course

Key Co-morbid Conditions/ Features Associated with the Disease

Methodology for Quantification of Patient Numbers

Top-Line Prevalence for Autism Spectrum Disorders (ASD)

Main Complications and Features of ASD

  • Type of ASD
  • Severity of ASD
  • Level of Cognitive Function in ASD Patients
  • The Seizure Type in ASD Patients with Epilepsy
  • Behavioural Dysfunction in ASD Patients
  • Motor and Muscle Impairment in ASD Patients

Abbreviations used in the Report

Other Black Swan Analysis Publications

Black Swan Analysis Online Patient-Based Databases

Patient-Based Offering

Online Pricing Data and Platforms

References

Appendix

List of Tables & Figures

  • Prevalence of ASD, total (000s)
  • Prevalence of ASD, males (000s)
  • Prevalence of ASD, females (000s)
  • Prevalence of ASD from birth to 19 years of age, total (000s)
  • Prevalence of ASD from birth to 19 years of age, males (000s)
  • Prevalence of ASD from birth to 19 years of age, females (000s)
  • Type of ASD, total (000s)
  • Severity of ASD, total (000s)
  • Cognitive Function of ASD patients by IQ score, total (000s)
  • Gastrointestinal Symptoms of ASD patients, total (000s)
  • Epileptic Seizure Types in ASD patients, total (000s)
  • Number of Hours Slept in ASD patients, total (000s)
  • ADHD in ASD Patients, total (000s)
  • OCD in Asperger's syndrome patients, total (000s)
  • Anxiety Disorder in ASD patients, total (000s)
  • Depression Disorder in ASD patients, total (000s)
  • Gross Motor Delay in ASD patients, total (000s)
  • Hypotonia in ASD patients, total (000s)
  • Abbreviations and acronyms used in the Report
  • USA Prevalence of ASD by 5-yr age cohort, males (000s)
  • USA Prevalence of ASD by 5-yr age cohort, females (000s)
  • France Prevalence of ASD by 5-yr age cohort, males (000s)
  • France Prevalence of ASD by 5-yr age cohort, females (000s)
  • Germany Prevalence of ASD by 5-yr age cohort, males (000s)
  • Germany Prevalence of ASD by 5-yr age cohort, females (000s)
  • Italy Prevalence of ASD by 5-yr age cohort, males (000s)
  • Italy Prevalence of ASD by 5-yr age cohort, females (000s)
  • Spain Prevalence of ASD by 5-yr age cohort, males (000s)
  • Spain Prevalence of ASD by 5-yr age cohort, females (000s)
  • United Kingdom Prevalence of ASD by 5-yr age cohort, males (000s)
  • United Kingdom Prevalence of ASD by 5-yr age cohort, females (000s)
  • Brazil Prevalence of ASD by 5-yr age cohort, males (000s)
  • Brazil Prevalence of ASD by 5-yr age cohort, females (000s)
  • Japan Prevalence of ASD by 5-yr age cohort, males (000s)
  • Japan Prevalence of ASD by 5-yr age cohort, females (000s)
  • India Prevalence of ASD by 5-yr age cohort, males (000s)
  • India Prevalence of ASD by 5-yr age cohort, females (000s)
  • Denmark Prevalence of ASD by 5-yr age cohort, males (000s)
  • Denmark Prevalence of ASD by 5-yr age cohort, females (000s)
  • Sweden Prevalence of ASD by 5-yr age cohort, males (000s)
  • Sweden Prevalence of ASD by 5-yr age cohort, females (000s)
  • China Prevalence of ASD by 5-yr age cohort, males (000s)
  • China Prevalence of ASD by 5-yr age cohort, females (000s)
Back to Top